DOCSLIB.ORG

2014 WEHI Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2014 WEHI Annual Report ANNUAL REPORT JULY–DECEMBER 2014 CANCER | IMMUNE DISORDERS | INFECTIOUS DISEASE CONTENTS 1 About the institute The Walter and Eliza Hall Institute of Medical Research 2 President’s report 3 Director’s report Parkville campus 1G Royal Parade 4 The board Parkville Victoria 3052 Australia 5 Vale Professor Donald Metcalf Telephone: +61 3 9345 2555 6 Research highlights Bundoora campus 4 Research Avenue 13 Chief operating officer’s report La Trobe R&D Park 14 Our supporters Bundoora Victoria 3086 Australia Telephone: +61 3 9345 2200 16 Members of the institute www.wehi.edu.au 17 Institute organisation www.facebook.com/WEHIresearch www.twitter.com/WEHI_research 18 Statistical summary www.youtube.com/WEHImovies 19 The period at a glance ABN 12 004 251 423 20 Supporting our research © The Walter and Eliza Hall Institute of Medical Research 2015 Produced by the Walter and Eliza Hall Institute’s Communications and Marketing department Cover image Director Art of Science finalist 2014 Douglas J Hilton BSc Mon BSc(Hons) PhD Melb FAA FTSE FAHMS A merging of worlds by Dr Lachlan Whitehead, Systems Biology and Personalised Medicine division, and Mr Caleb Dawson, Assistant Director Molecular Medicine division. David Vaux MB BS BMedSc PhD Melb FAA Platelets are cells that make your blood clot when you get a cut, stopping the bleeding. Understanding how platelets form and the role they play in human Chief Operating Officer development and growth may help us develop Samantha Ludolf treatments for diseases in which someone has too BA(Hons) Lincoln MEnterp Melb few or too many platelets. This image shows partially analysed data that is normally buried by the computer Chief Financial Officer as it converts images of blood samples into numbers. Ian Coulson Circles mark the position of platelets, with coloured BEc Monash FCA GAICD rings indicating distances to the nearest blood cell. This beautiful image would not normally be seen, had the researchers not probed the code. Honorary Governor and Patron Sir Gustav Nossal AC CBE MB BS BSc(Med) Syd PhD Melb HonLLD Mon HonLLD Melb HonMD Mainz HonMD Ncl HonMD Leeds HonMD UWA HonDSc Syd HonDSc Qld HonDSc ANU HonDSc UNSW HonDSc LaT HonDSc McMaster HonDSc Oxon FRCP FRACP FRCPA FRACOG(Hon) FRCPath FRACGP FRSE FTSE FAA FRS ANNUAL We acknowledge the traditional owners and REPORT custodians of the land on which our campuses are JULY–DECEMBER 2014 located, the Wurundjeri people of the Kulin nation, CANCER | IMMUNE DISORDERS | INFECTIOUS DISEASE and pay our respects to their elders past and present. OUR MISSION INSTITUTE AT Mastery of disease A GLANCE through discovery OUR VISION 1011 To be an innovative medical research staff and students institute that engages and enriches society and improves health outcomes through 9staff and31 students diseases 40+impacted by institute research 3publications81 discovery, translation and education. 40+ disease impacted by institute research ABOUT THE INSTITUTE 9staff and31 students diseases 40+impacted by institute research 3publications81 167 The Walter and Eliza Hall Institute is Australia’s national1staff and 0and international students0 trials diseases impacted by institute research 3publications81 based9 on institute31 discoveries publicationsinstitute 40+and visiting speakers people came to an event at the institute oldest medical research institute, and is 130 5516 celebrating its centenary in 2015. For 100 years we have been making discoveries for humanity, 9staff and31 students diseases 40+impacted by institute research 3publications81 improving the health of people in Australia and around the world. 100 The institute has more than 750 researchers who are working to national and understand, prevent and treat diseases, with a focus on cancers, international trials immune disorders and infectious disease. 9staff and31 students diseases 40+impacted by institute researchbased on institute3publications8 1 discoveries Our past discoveries include identifying colony stimulatingnational1 and factors0 international0 (CSFs), trials which have helped more than 20 million cancer patientsbased recover on institute from discoveries institute1 and3 visiting0 speakers people5 came to5 an event1 at 6the institute chemotherapy; treating immune disorders with drugs that suppress national and international trials abnormal immune responses; and developing techniques for growing flu 100 based on institute discoveries people came to an event at the institute national1 and0 international0 trials institute1 and3 visiting0 speakers 5516 viruses at sufficient quantities for flu vaccines.based on institute discoveries institute1 and3 visiting0 speakers people5 came to5 an event1 at 6the institute The institute offers postgraduate training as the Department of Medical 74 Biology of The University of Melbourne, and is affiliated with The University institute and of Melbourne and The Royal Melbourne Hospital. visiting speakers national1 and0 international0 trials based on institute discoveries institute1 and3 visiting0 speakers people5 came to5 an event1 at 6the institute in the six months from July to December 2014. PRESIDENT’S REPORT It is my privilege to once again report institute’s reputation has been built and collaborators with whom we have to our stakeholders. This report covers is maintained. worked for so many years have provided only six months due to the change We are also very conscious of the a real edge that has helped the institute in our financial year, which sees us extraordinary philanthropic support and to remain innovative and world leading. moving to a calendar rather than the collaboration from other institutions We have also just completed our traditional financial year. We feel this that has underpinned our growth and strategic review and have formulated the better aligns with the government success. It is remarkable to look at the strategic priorities that we will pursue grant cycle. institute’s first annual financial accounts over the next five years. We look forward The latter part of 2014 continued dated almost a century ago and see to sharing these with all stakeholders to be a challenging one for medical the four familiar names that have been and to celebrating the centenary research institutes in Australia. Budget involved with us all the way. throughout 2015. Our hope is that as uncertainties persisted at the federal The Walter and Eliza Hall Trust, which a consequence new supporters will be level, particularly with respect to the enabled our establishment, continues to attracted to the wonderful work of our proposed Medical Research Future support us as do other partners from our scientific team. Fund, and the newly elected Victorian early days: The University of Melbourne, Government has yet to announce any The Royal Melbourne Hospital and CSL initiatives for the sector. Ltd. In fact, our original premises were Putting all this into context however, in the then Melbourne Hospital, and we have now entered the institute’s part of these were sublet for a period centenary year, which not only gives to the then Commonwealth Serum Mr Christopher Thomas us many reasons to celebrate, but Laboratories (now CSL Ltd) as they built President also many reasons to reflect. The their own facilities. Walter and Eliza Hall Institute extraordinary achievements of the Thus we are reminded that although institute’s scientists, and those who government funding is clearly critical to have supported them since we started, medical research institutes throughout are the foundations on which the Australia, the philanthropists and other 2 Walter and Eliza Hall Institute Annual Report 2014 DIRECTOR’S REPORT As director, I am always excited to hear promising young researchers missed coming decades. A revised model for our scientists’ plans for their research. out on receiving government support for capitalising the fund was announced Medical research is a rapidly moving their research. in December 2014, and has the strong field and, at the institute, we strive to Talented young researchers are support of Australia’s major medical ensure that the facilities and support vital for the future of medical research research institutes and universities. we provide our researchers gives them in Australia. We are mindful of the Enhanced funding of medical research every opportunity to pursue new and challenges our early-career researchers is crucial if Australian researchers are to rewarding avenues of discovery. face in obtaining funding for their continue improving our nation’s health This year, we have been developing innovative, long-term and sometimes into the future. a new five-year strategic plan that will risky research ideas. In response, we As you read this, our centenary year follow on from our current plan, guiding have initiated a campaign to establish will be well underway. An exciting line- our operations from 2015 to 2020. Centenary fellowships for our most up of events to celebrate the institute’s Institute staff, students, supporters promising young researchers. Over the achievements has been put together. I and collaborators have been consulted next five years we have the ambitious am looking forward to meeting many of about how the institute can maximise goal of securing 100 fellowships with the you, our existing supporters, at these the benefits it provides to the community support of our donors. events, as well as introducing many through world-class research. In October, I began a two-year term more Australians to the 100 years of Our researchers have made many as the president
Load more

Recommended publications
  • Patterns, Paradoxes and Personalities Medical History Museum, University of Melbourne the Story of Cancer Is Complex and Extremely Personal
    THE cancer puzzle patterns, paradoxes and personalities Medical History Museum, University of Melbourne The story of cancer is complex and extremely personal. One in two Australian men and one in three Australian women will be diagnosed with cancer by the age of 85. For generations, doctors and researchers have been searching for remedies for this disease, which has long been shrouded in fear and dread. While surgery, radiotherapy and chemotherapy are still the main treatments, radically new approaches and technologies are emerging, together with a much more sophisticated understanding of the causes and very nature of cancer. Central to the story of cancer in Victoria has been the contribution of the University of Melbourne, in undertaking fundamental and applied research, developing treatments, training clinicians and scientists, educating the public, and advocating for change. Significant figures in the Melbourne Medical School, such as Professor Peter MacCallum, have helped build the infrastructure that underpins cancer services for the Victorian community. The cancer puzzle: Patterns, paradoxes and personalities explores the roles of individuals, public education campaigns and research efforts, as well as revealing patients’ insights through the work and writings of three contemporary artists who have cancer. the cancer puzzle PATTERNS, PARADOXES AND PERSONALITIES Edited by Jacqueline Healy Medical History Museum University of Melbourne Contents Foreword vii Published 2017 by the Medical History Museum, The exhibition The cancer puzzle: Patterns, paradoxes and personalities, Professor Mark Cook Faculty of Medicine, Dentistry and Health Sciences, curated by Dr Jacqueline Healy, was held at the Medical History University of Melbourne, Victoria, 3010, Australia Museum, University of Melbourne, from 1 August 2017 to Sponsor’s message ix 24 February 2018.
    [Show full text]
  • Lists of Members 1996
    Lists of Members Governing Bodies, Faculties, Boards, Academic and Administrative Staff 1996 Main Committees and Departmental Lists as at 1st February, 1996. Address All general correspondence directed to the University should be addressed to The Registrar, The University of Melbourne, Parkville, Victoria. Australia, 3052. Telephone: (03) 9344 4000 Fax: (03) 9344 5104 Contents UNIVERSITY OF MELBOURNE: SENIOR OFFICE BEARERS COUNCIL 1 *COMMI 11tES 2 4 COUNCILS OF HALLS OF RESIDENCE COMMITthE OF CONVOCATION 8 *ACADEMIC BOARD FACULTIES 10 BOARDS 13 PROFESSORS 21 22 PROFESSORIAL ASSOCIATES WITH 1-11LE OF PROFESSOR 28 READERS 30 PROFESSORS EMERITUS 35 HEADS OF AFFILIATED COLLEGES 40 HEADS OF HALLS OF RESIDENCE 40 TEACHING AND RESEARCH STAFF - Agriculture, Forestry and Horticulture 41 Architecture, Building and Planning 45 Arts 46 Economics and Commerce 53 Education 56 Engineering 60 Law 65 Medicine, Dentistry and Health Sciences 67 Melbourne Business School 99 Music 100 Science 101 Veterinary Science 107 Victorian College of the Arts 109 LIBRARY 112 FACULTY ADMINISTRATION 115 GRADUATE SCHOOL ADMINISTRATION 119 CENTRAL ADMINISTRATION 120 Office of the Vice-Chancellor and Principal 120 Academic Registrar's Division 122 Academic Services 122 Academic Administration 122 Academic Planning Support Unit 122 External Relations 122 The Graduate Centre 123 International Office 123 Student and Staff Services 123 Human Resources 125 Registrar's Division 126 Executive Services 126 Financial Operations 126 Information
    [Show full text]
  • Longitudinal Single Cell Fate of Hematopoiesis in Vivo Using Cellular Barcoding
    bioRxiv preprint doi: https://doi.org/10.1101/279406; this version posted March 9, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Longitudinal single cell fate of hematopoiesis in vivo using cellular barcoding and DiSNE movie visualization Short title: Longitudinal single cell fate in hematopoiesis Jerry Gao1,2, Dawn S. Lin1,2,3, Edmund Crampin,4,5,6, Shalin H. Naik1,2,3,* 1Molecular Medicine, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia 2Immunology, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia 3Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria 3010, Australia. 4Systems Biology Laboratory, University of Melbourne, Parkville, Victoria 3010, Australia 5Centre for Systems Genomics, University of Melbourne, Parkville, Victoria 3010, Australia 6ARC Centre of EXcellence in Convergent Bio-Nano Science and Technology, Melbourne School of Engineering, University of Melbourne, Parkville, Victoria 3010, Australia. *Corresponding author. bioRxiv preprint doi: https://doi.org/10.1101/279406; this version posted March 9, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available
    [Show full text]
  • 2010-2011 Annual Report
    Annual Report 2010-2011 Mastery of disease through discovery | www.wehi.edu.au Contents 1 About the institute 3 Director’s and Chairman’s report 5 Discovery 8 Cancer and Haematology 10 Stem Cells and Cancer 12 Molecular Genetics of Cancer 14 Chemical Biology 16 Molecular Medicine 18 Structural Biology 20 Bioinformatics 22 Infection and Immunity 24 Immunology The Walter and Eliza Hall Institute 26 Autoimmunity and Transplantation of Medical Research 28 Cell Signalling and Cell Death 1G Royal Parade 30 Inflammation Parkville Victoria 3052 Australia Telephone: (+61 3) 9345 2555 32 Molecular Immunology Facsimile: (+61 3) 9347 0852 34 Publications WEHI Biotechnology Centre 36 Awards 4 Research Avenue 37 Translation La Trobe R&D Park Bundoora Victoria 3086 Australia Translating our research 38 Telephone: (+61 3) 9345 2200 40 Developing our research Facsimile: (+61 3) 9345 2211 42 Patents www.wehi.edu.au www.facebook.com/WEHIresearch 43 Education www.twitter.com/WEHI_research 46 2010-11 graduates ABN 12 004 251 423 47 Seminars Acknowledgements 48 Institute awards Produced by the institute’s Community Relations department 49 Engagement Managing editor: Penny Fannin Editor: Liz Williams 51 Strategic partners Writers: Liz Williams, Vanessa Solomon and Julie Tester 52 Scientific and medical community Design and production: Simon Taplin Photography: Czesia Markiewicz and Cameron Wells 54 Public engagement 57 Engagement with schools Cover image 58 Donor and bequestor engagement Art in Science finalist 2010 Vessel webs 59 Sustainability Dr Leigh Coultas, Cancer and Haematology division 60 The Board This image shows the delicate intricacy in the developing eye of a transient population of web-like blood vessels.
    [Show full text]
  • Survey of Commercial Outcomes from Public Research (Scopr) 2019 Report
    techtransfer.org.au SURVEY OF COMMERCIAL OUTCOMES FROM PUBLIC RESEARCH (SCOPR) 2019 REPORT Survey and report delivered by FOREWORD There is an ever-present imperative to capture the commercial value of our research endeavour for our future wellbeing. To do so strategically, decision makers from laboratory, institutional and government levels need insights into how the research sector is currently engaging with industry to transfer knowledge and innovation, and thereby deliver benefits to our society from the fruits of our research. For many years in Australia there has been a focus on improving innovation metrics, thus I am delighted to acknowledge the initiative of gemaker and Knowledge Commercialisation Australasia (KCA) in producing the inaugural Survey of Commercial Outcomes from Public Research (SCOPR). The SCOPR takes its lead from the National Survey of Research Commercialisation (NSRC) produced since 2000 by the Department of Industry, Science, Energy and Resources. To avoid duplication, the Department has decided to cease the NSRC and will work with KCA to share knowledge, and access data collected by SCOPR. As we face the COVID-19 pandemic, effective knowledge transfer is more important than ever, so I hope that this report will spur our research institutions to even greater achievements. Realising effective knowledge transfer will depend on having skilled commercialisation professionals who can help researchers turn great ideas into beneficial products and services. I applaud KCA’s support for technology transfer professionals
    [Show full text]
  • The Bio21 Institute's 2020 Annual Report Is Available to Download
    Annual Report 2020 Image of the coronavirus SARS-CoV-2 taken by Andrew Leis and Jason Roberts. Courtesy of the Doherty Institute. The Bio21 Molecular Science and Director Associate Director – Platform Biotechnology Institute Professor Michael W. Parker Infrastructure University of Melbourne DPhil (Oxon) FAA FAHMS Professor Malcolm McConville PhD 30 Flemington Road Deputy Director Associate Director – Commercialisation Parkville Victoria 3010 Professor Frances Separovic AO Professor Spencer Williams PhD Telephone: (03) 8344 2220 PhD FAA www.bio21.unimelb.edu.au Associate Director – Engagement @Bio21Institute Professor Sally Gras PhD @Bio21Institute Scientific Research Manager Dr David Keizer, PhD Produced by the Bio21 Molecular Science and Biotechnology External Relations Advisor,b Bio21 Florienne Institute Loder Annual Report 2020 Contents Our Mission 2 Our Vision 2 About the Institute 3 Director’s Message 4 Bio21 Leadership 8 Deputy Director, Professor Emeritus Frances Separovic AO 8 Associate Director Engagement – Professor Sally Gras 10 Associate Director Commercialisation – Professor Spencer Williams 13 Associate Director Platform Infrastructure – Professor Malcolm McConville 14 ACRF Facility for Innovative Cancer Drug Discovery 16 Impacts of Research 19 OHS Report 31 Equity Diversity and Inclusion 32 Industry Engagement and Commercialisation 35 Announcing the Ruth Bishop Building and Ian Holmes Imaging Centre 36 Events and Conferences 39 Graduate Research Students and Early Career Researchers 41 Institute Members Honoured 42 Grant Successes 43 Governance 46 Bio21 Scientific Research Team 47 Bio21 Research Groups 48 Bio21 People 50 Institute in Numbers 56 Bio21 Institute Theses submitted in 2020 57 Bio21 Steering Committee 58 Industry partners 63 Produced by the Bio21 Molecular Science aFontn Front cover image: Bio21 precinct aerial photograph, courtesy of Kane Jarrod Photography.
    [Show full text]
  • 2Nd Postdoc Methods Symposium Program
    Program Thursday, 13th September Event Approximate Time Location Registration Opens 8:30 – 9:00 Tapestry Lounge (in front of the Davis Auditorium) Session 1 9:00 – 10:20 Davis Auditorium 9:00 – 9:05 Organising Committee Welcome and Introductions 9:05 – 9:20 Daniel Brown An overview of single-cell omics methods, from Walter and Eliza Hall Institute technology to applications 9:20 – 9:35 Belinda Phipson Kidneys in a dish: examining the reproducibility Murdoch Children’s Research Institute of organoid differentiation using transcriptomics 9:35 – 9:50 Joanna Sacharz SELEX: In search of solubilizing nucleic acids Bio21 Institute, University of Melbourne KEYNOTE: A primer on single cell RNA-seq analysis 9:50 – 10:20 Matthew Richie Walter and Eliza Hall Institute Morning Tea 10:20 – 11:00 Tapestry Lounge posters & sponsor exhibits 2nd Postdoctoral Methods Symposium 2018 #PDMS2018 Event Approximate Time Location Session 2 11:00 – 12:15 Davis Auditorium MCFP sponsored talk Biological Imaging via Helium ion Microscopy 11:00 – 11:15 Babak Nasr University of Melbourne 11:15 – 11:30 Mohamed Fareh Single-molecule fluorescence reveals the Peter MacCallum Cancer Centre dynamics of microRNA recognition by Dicer- TRBP complex 11:30 – 11:45 Charis Teh Capturing the cellular gymnastics of survival Walter and Eliza Hall institute and killer proteins by mass cytometry (CyTOF) 11:45 – 12:00 Jieqiong Lou Phasor analysis and image correlation Bio21 Institute, University of Melbourne spectroscopy of histone FLIM/FRET reveals spatiotemporal regulation of chromatin organization by the DNA damage response. Session 2 Flash talks 12:00 – 12:15 Davis Auditorium Rachel Lundie Flow FISH as a method to elucidate the Walter and Eliza Hall Institute transcriptional effects of M.
    [Show full text]
  • Ngv Annual Report 2019 / 20
    ANNUAL REPORT 2019 / 20 COUNCIL OF TRUSTEES OF THE NATIONAL GALLERY OF VICTORIA, AUSTRALIA NGV ANNUAL REPORT 2019 / 20 COUNCIL OF TRUSTEES OF THE NATIONAL GALLERY OF VICTORIA, AUSTRALIA NGV INTERNATIONAL 180 St Kilda Road THE IAN POTTER CENTRE: NGV AUSTRALIA Federation Square National Gallery of Victoria PO Box 7259 Melbourne VIC 3004 Australia +61 3 8620 2222 www.ngv.vic.gov.au ISSN: 2206-4982 RESPONSIBLE BODY’S DECLARATION In accordance with the Financial Management Act 1994, I am pleased to present the Council of Trustees of the National Gallery of Victoria’s Annual Report for the year ending 30 June 2020. Janet Whiting AM President, Council of Trustees 27 August 2020 (cover) KAWS American 1974– GONE 2019 (installation view) patinated and painted bronze 700.0 x 710.5 x 294.0 cm Commissioned by the National Gallery of Victoria, 2020 (2020.177) © KAWS CONTENTS OVERVIEW SUPPORT About the National Gallery of Victoria 5 Affiliated groups 137 President’s foreword 6 2019/20 Donors 140 Director’s review 8 NGV Foundation Members 146 Strategic framework 10 Felton Society Members 154 Report against output targets 11 NGV Life Members 156 Emeritus Trustees and Foundation Board members 157 2019/20 PERFORMANCE REPORT The Felton Bequest 157 Bringing art and design to life 13 Partners 158 Connecting audiences 20 Realising our potential 24 GOVERNANCE Building for the future 26 Council of Trustees 167 Sharing our vision 28 Council Committees and working groups 169 Exhibitions Listing 32 Workforce data 170 Acquisition Listing 36 Organisational structure 173 Publications Listing 64 Other corporate reports 174 Disclosure index 184 2019/20 FINANCIAL REPORT Five-year financial summary 71 Independent audit report 74 Financial statements 76 Notes to the financial statements 82 OVERVIEW ABOUT THE NATIONAL GALLERY OF VICTORIA ORIGINS STATE COLLECTION Founded in 1861, the National Gallery of Victoria (NGV) is The State Collection comprises approximately 73,000 works Australia’s oldest public art gallery.
    [Show full text]
  • Drug Discovery and Technology Capabilities at WEHI Melbourne, Australia History of WEHI
    Drug Discovery and Technology Capabilities at WEHI Melbourne, Australia History of WEHI • Established 1915 • Focused on the fundamental principles of medical biology to mitigate disease • Independent Research Institute affiliated with University of Melbourne, Royal Melbourne Hospital and the Victorian Comprehensive Cancer Center WEHI Overview 90 laboratories working on 120 Clinical trials 50+ diseases currently underway > +30 million patients world wide have 1200+ researchers benefited from our research and staff World-Class Research Across a Broad Range of Therapeutic Areas • WEHI performs influential basic and translational research focused on four key therapeutic areas: – Cancer – Immunology & Inflammation – Infectious diseases – Ageing and development Font size proportional to research effort per topic Fulfilling Our Mission • WEHI was ranked 19th in the 2019 Nature Index for global not-for-profit/non-governmental organizations. • Translating discoveries: Venetoclax = New targeted treatment for Chronic Lymphocytic Leukaemia approved by FDA in 2016. • Gender Equity in Research: WEHI is recipient of SAGE Athena SWAN Award + membership of Male Champions of Change. • Increased funding partnership with State government ➣ State government invests $18M in WEHI National Drug Discovery Centre (in addition to contributions announced by Federal government). History of our Drug Discovery Centre • First academic drug discovery infrastructure at an Australian research institute – High-throughput screening facility – Medicinal chemistry laboratories
    [Show full text]
  • The Lasting Legacy of Donald Metcalf Brty Ku Samson
    14 The Lasting Legacy of Donald Metcalf BRTY KU Samson onald Metcalf, Among the many hon- MD, considered ors and awards he received “the father of were the Albert Lasker oncology-times.com modern hematol- Award for Clinical Medical • Dogy,” died Dec. 15, at age 85, Research, the Gairdner surrounded by his family, in Foundation International Melbourne, Australia. Award, the Royal Medal Professor Emeritus at the of the Royal Society, the University of Melbourne Victoria Prize, and the and the Cancer Council Lifetime Achievement Victoria’s Carden Fellow in Award from American the Division of Cancer and Association for Cancer February 10, 2015 Hematology at the Walter Research in 2007. • and Eliza Hall Institute of “As an experimental pa- Medical Research, he was thologist, I have studied the the first to discover colony- manner in which mature stimulating factors (CSFs), blood cells are formed by hormones that control white ancestral cells in the bone blood cell production to marrow. This required the bolster recovery after cancer development of clonal cul- treatment. ture systems, allowing the Metcalf worked at the progeny of individual cells Oncology Times Walter and Eliza Hall to be analyzed,” Metcalf Institute for 60 years, from wrote for a biographi- 1954 to 2014. After he devel- and Eliza Hall Institute Walter cal sketch for the National oped pancreatic cancer this DONALD W. METCALF, MD (1929-2014) Academy of Sciences at the past August, he continued time of his election as a his research at home until member in 1987. October, when he conducted his final weakened by chemotherapy.
    [Show full text]
  • 2020 Annual Report
    2020 Annual Report Make this cover come alive with augmented reality. Details on inside back cover. Contents The Walter and Eliza Hall Institute About WEHI 1 of Medical Research President’s report 2 Parkville campus 1G Royal Parade Director’s report 3 Parkville Victoria 3052 Australia Telephone: +61 3 9345 2555 WEHI’s new brand launched 4 Bundoora campus 4 Research Avenue Our supporters 10 La Trobe R&D Park Bundoora Victoria 3086 Australia Exceptional science and people 13 Telephone: +61 3 9345 2200 www.wehi.edu.au 2020 graduates 38 WEHIresearch Patents granted in 2020 40 WEHI_research WEHI_research WEHImovies A remarkable place 41 Walter and Eliza Hall Institute Operational overview 42 ABN 12 004 251 423 © The Walter and Eliza Hall Institute Expanding connections with our alumni 45 of Medical Research 2021 Diversity and inclusion 46 Produced by the WEHI’s Communications and Marketing department Working towards reconciliation 48 Director Organisation and governance 49 Douglas J Hilton AO BSc Mon BSc(Hons) PhD Melb FAA FTSE FAHMS WEHI Board 50 Deputy Director, Scientific Strategy WEHI organisation 52 Alan Cowman AC BSc(Hons) Griffith PhD Melb FAA FRS FASM FASP Members of WEHI 54 Chief Operating Officer WEHI supporters 56 Carolyn MacDonald BArts (Journalism) RMIT 2020 Board Subcommittees 58 Chief Financial Officer 2020 Financial Statements 59 Joel Chibert BCom Melb GradDipCA FAICD Financial statements contents 60 Company Secretary Mark Licciardo Statistical summary 94 BBus(Acc) GradDip CSP FGIA FCIS FAICD The year at a glance 98 Honorary
    [Show full text]
  • M. Moore: Introduction for Donald Metcalf
    Haematology and Blood Transfusion Vol. 31 Modern Trends in Human Leukemia VII Edited by Neth, Gallo, Greaves, and Kabisch © Springer-Verlag Berlin Heidelberg 1987 Introduction for Donald Metcalf M. Moore 1 It is a personal pleasure to introduce my understand the environment, the man, and friend and former colleague, Donald Met­ the interplay of chance and the prepared calf. He is best recognized as one of the mind. In 1965 the Nobel Laureate, Sir Mac­ founding fathers of modern experimental farlane Burnet, retired as Director of the hematology, but we should not forget his Walter and Eliza Hall Institute for Medical pioneering work on the thymus. From 1956 Research (WEHI), appointing as his suc­ and the decade thereafter, Don undertook a cessors his two proteges, Gus Nossal as Di­ series of elegant studies on thymic cell kin­ rector and Don Metcalf as Assistant Direc­ etics and was one of the first to analyze the tor and Head of the Cancer Research Unit. impact of thymectomy and thymic grafting This was a wise decision, since Don re­ on lymphopoiesis. Indeed, he should be con­ mained relatively unburdened by adminis­ sidered the first to demonstrate the effects of trative responsibilities, which he naturally thymectomy on lymphoid tissue and the au­ finds irksome, and was able to pursue his sci­ tonomous control of lymphocyte prolifer­ entific interests. The "golden age of immu­ ation within the thymus. In addition, his nology" can be considered to have begun in analysis of leukemogenesis in AKR mice is the mid-1960s and the Hall Institute was still considered definitive, revealing his abil­ very much at the forefront.
    [Show full text]